Public Release: 11-Feb-2015 Diabetes drug spurs host defense
Patients with chronic granulomatous disease (CGD), a rare inherited disorder, lack a functional enzyme, known as NADPH oxidase, which impairs their ability to produce a variety of oxidant molecules, known as reactive oxygen species (ROS), in response ...
EurekAlert (press release) - Wed, 11 Feb 2015 13:22

Type 2 diabetes medication pioglitazone helps fight bacterial infections
Diabetes.co.uk - Thu, 12 Feb 2015 05:18

Diabetes medication can help white blood cells fight bacterial infections
News-Medical.net - Thu, 12 Feb 2015 02:18

Immune Deficiency Foundation Launches New Website Dedicated to Those ...
3, 2015 /PRNewswire/ -- The Immune Deficiency Foundation (IDF) announces the launch of LivingwithCGD.org, a new website dedicated to those living with Chronic Granulomatous Disease (CGD). The site will provide the latest news and information ...
PR Newswire (press release) - Tue, 03 Feb 2015 14:41



More smokers eligible for free lung screenings
The scans also revealed a variety of other health conditions, the most common being emphysema and chronic obstructive pulmonary disease, or COPD, followed by coronary artery disease. An uptick in ... The screenings can turn up false positives, often ...
The Courier-Journal - Sat, 28 Feb 2015 06:03



Leprosy Not So Ancient Disease: Three New Cases Diagnosed in Florida
This chronic disease also known as Hansen's disease manifests with a plethora of symptoms, from nerve granulomas and respiratory tract granulomas, to skin and eye lesions, sensitivity issues (patients often lack the ability of feeling pain) weakness ...
WallStreet OTC - Sat, 28 Feb 2015 12:37

Finding the Patient With Primary Biliary Cirrhosis
Primary biliary cirrhosis (PBC) is a chronic progressive disorder of presumed autoimmune cause that appears to be increasing in case frequency in parallel with a rising incidence of other autoimmune conditions. PBC typically affects women more than men ...
Medscape - Fri, 27 Feb 2015 07:22

Horizon Pharma's (HZNP) CEO Timothy Walbert on Q4 2014 Results - Earnings ...
ACTIMMUNE, a bioengineered form of interferon gamma-1b, is our first orphan disease product and is currently approved for treatment of chronic granulomatous disease or CGD and severe malignant osteopetrosis or SMO. In addition to these 2 indications, ...
Seeking Alpha (registration) - Fri, 27 Feb 2015 09:05

Top UBS Health Care Stocks to Buy for 2015 and Beyond
The company's best known products include Actimmune, for reducing the frequency and severity of serious infections associated with chronic granulomatous disease, and Duexis, a proprietary tablet formulation for the relief of signs and symptoms of ...
24/7 Wall St. - Tue, 24 Feb 2015 07:00



Biotechnology Stock's Cyclacel Pharmaceuticals, (NASDAQ:CYCC) Skyrocketed ...
It offers ACTIMMUNE for reducing the frequency and severity of serious infections associated with chronic granulomatous disease; DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis (RA) and ...
wsnewspublishers - Fri, 27 Feb 2015 08:30


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014